Angela Falco

4.5k total citations
61 papers, 3.3k citations indexed

About

Angela Falco is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Angela Falco has authored 61 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Angela Falco's work include Antioxidant Activity and Oxidative Stress (8 papers), Tissue Engineering and Regenerative Medicine (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Angela Falco is often cited by papers focused on Antioxidant Activity and Oxidative Stress (8 papers), Tissue Engineering and Regenerative Medicine (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Angela Falco collaborates with scholars based in Italy, United States and Switzerland. Angela Falco's co-authors include Giovanni Davı̀, Carlo Patrono, Stefania Basili, Patrizia Ferroni, Giovanni Ciabattoni, G. Davı̀, Michele Nutini, Maria Teresa Guagnano, S Sensi and Federico Quaini and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Angela Falco

61 papers receiving 3.2k citations

Peers

Angela Falco
Angela Falco
Citations per year, relative to Angela Falco Angela Falco (= 1×) peers Johannes Hulthe

Countries citing papers authored by Angela Falco

Since Specialization
Citations

This map shows the geographic impact of Angela Falco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Falco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Falco more than expected).

Fields of papers citing papers by Angela Falco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Falco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Falco. The network helps show where Angela Falco may publish in the future.

Co-authorship network of co-authors of Angela Falco

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Falco. A scholar is included among the top collaborators of Angela Falco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Falco. Angela Falco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rafaniello, Concetta, Angela Falco, Luigi Di Costanzo, et al.. (2023). A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database. Biomedicines. 11(8). 2162–2162. 2 indexed citations
2.
Mazzaschi, Giulia, Gianluca Milanese, Paolo Pagano, et al.. (2020). Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 31. 105781–105781. 5 indexed citations
3.
Rosellini, Elisabetta, Denise Madeddu, Niccoletta Barbani, et al.. (2020). Development of Biomimetic Alginate/Gelatin/Elastin Sponges with Recognition Properties toward Bioactive Peptides for Cardiac Tissue Engineering. Biomimetics. 5(4). 67–67. 17 indexed citations
4.
Mazzaschi, Giulia, Gianluca Milanese, Paolo Pagano, et al.. (2020). Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC. Lung Cancer. 144. 30–39. 27 indexed citations
5.
Bonelli, Mara, Graziana Digiacomo, Claudia Fumarola, et al.. (2017). Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. Neoplasia. 19(8). 637–648. 82 indexed citations
6.
Savi, Monia, Caterina Frati, Stefano Cavalli, et al.. (2017). Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors. Pharmacological Research. 127. 15–25. 14 indexed citations
7.
Massai, Diana, Giuseppe Isu, Denise Madeddu, et al.. (2016). A Versatile Bioreactor for Dynamic Suspension Cell Culture. Application to the Culture of Cancer Cell Spheroids. PLoS ONE. 11(5). e0154610–e0154610. 46 indexed citations
8.
Bonelli, Mara, Andrea Cavazzoni, Francesca Saccani, et al.. (2015). Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. Molecular Cancer Therapeutics. 14(8). 1916–1927. 32 indexed citations
9.
Urbanek, Konrad, Caterina Frati, Gallia Graiani, et al.. (2015). Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors. Current Drug Targets. 16(8). 884–894. 6 indexed citations
10.
Ampollini, Luca, Denise Madeddu, Angela Falco, et al.. (2014). Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells†. European Journal of Cardio-Thoracic Surgery. 46(6). e103–e112. 10 indexed citations
11.
Dragani, Alfredo, Angela Falco, Francesca Santilli, et al.. (2012). Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism. Thrombosis and Haemostasis. 108(9). 533–542. 18 indexed citations
12.
Lessiani, Gianfranco, et al.. (2009). Soluble CD40 ligand and endothelial dysfunction in aspirin‐treated polycythaemia vera patients. British Journal of Haematology. 145(4). 538–540. 8 indexed citations
13.
Lessiani, Gianfranco, et al.. (2008). Clinical research Prevalence of deep vein thrombosis in patients affected by exacerbation of mild to moderate COPD at stage I-II of GOLD classification. Archives of Medical Science. 4(1). 62–65. 3 indexed citations
14.
Lessiani, Gianfranco, et al.. (2008). Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis. Journal of Thrombosis and Thrombolysis. 27(3). 348–351. 12 indexed citations
15.
Ciabattoni, Giovanni, Ettore Porreca, Concetta Di Febbo, et al.. (2006). Determinants of platelet activation in Alzheimer's disease. Neurobiology of Aging. 28(3). 336–342. 66 indexed citations
16.
Ferroni, Patrizia, Stefania Basili, Angela Falco, & Giovanni Davı̀. (2004). Inflammation, insulin resistance, and obesity. Current Atherosclerosis Reports. 6(6). 424–431. 107 indexed citations
17.
Ferroni, Patrizia, Stefania Basili, Angela Falco, & G. Davı̀. (2004). Platelet activation in type 2 diabetes mellitus. Journal of Thrombosis and Haemostasis. 2(8). 1282–1291. 346 indexed citations
18.
Falco, Angela, et al.. (2004). Increased soluble CD40 ligand levels in cystic fibrosis. Journal of Thrombosis and Haemostasis. 2(4). 557–560. 24 indexed citations
19.
Cristofaro, Raimondo De, Bianca Rocca, Ester Vitacolonna, et al.. (2003). Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. Journal of Thrombosis and Haemostasis. 1(2). 250–256. 56 indexed citations
20.
Davı̀, Giovanni, Maria Teresa Guagnano, Giovanni Ciabattoni, et al.. (2002). Platelet Activation in Obese Women. JAMA. 288(16). 2008–2008. 450 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026